Agency Forms Undergoing Paperwork Reduction Act Review, 66030-66031 [2016-23072]

Download as PDF mstockstill on DSK3G9T082PROD with NOTICES 66030 Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices of the meeting will be included in the official record of the meeting. The meeting will be webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: http:// www.cdc.gov/vaccines/acip/index.html. Purpose: The committee is charged with advising the Director, CDC, on the appropriate use of immunizing agents. In addition, under 42 U.S.C. §1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention and appear on the CDC immunization schedules must be covered by applicable health plans. Matters for Discussion: The agenda will include discussions on: Meningococcal vaccines; human papillomavirus vaccines; influenza; hepatitis vaccines; pertussis vaccines; Respiratory Syncytial Virus (RSV); child and adolescent immunization schedule; adult immunization schedule; herpes zoster vaccine; yellow fever vaccine; pneumococcal vaccine and vaccine supply. A recommendation vote is scheduled for Hepatitis B vaccine, pertussis vaccine, human papillomavirus vaccines, meningococcal vaccines, child and adolescent immunization schedule, and adult immunization schedule. A Vaccines for Children (VFC) vote is scheduled for human papillomavirus vaccines, Hepatitis B vaccine and meningococcal vaccines. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Stephanie Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30329, Telephone: (404) 639–8836; Email: ACIP@ CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 Prevention and the Agency for Toxic Substances and Disease Registry. Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–23053 Filed 9–23–16; 8:45 am] [FR Doc. 2016–23055 Filed 9–23–16; 8:45 am] BILLING CODE 4160–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) GH16–007, Operations Research (Implementation Science) for Strengthening Global Health Protection Implementation. Times and dates: 9:00 a.m.–2:00 p.m., EDT, Panel A, October 18, 2016 (Closed); 9:00 a.m.–2:00 p.m., EDT, Panel B, October 19, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to GH16–007 Operations Research (Implementation Science) for Strengthening Global Health Protection Implementation. Contact person for more information: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30329, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–16–0457] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written E:\FR\FM\26SEN1.SGM 26SEN1 66031 Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices comments should be received within 30 days of this notice. Proposed Project Aggregate Reports for Tuberculosis Program Evaluation (OMB Control Number 0920–0457)—Reinstatement Without Change of a Previously Approved Collection—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC, NCHHSTP, Division of Tuberculosis Elimination (DTBE) proposes a reinstatement without change of the Aggregate Reports for Tuberculosis Program Evaluation, previously approved under OMB Control Number 0920–0457. This request is for a three-year clearance. There are no revisions to the report forms, data definitions, or reporting instructions. DTBE is the lead agency for tuberculosis elimination in the United States. To ensure the elimination of tuberculosis in the United States, CDC monitors indicators for key program activities, such as finding tuberculosis infections in recent contacts of cases and in other persons likely to be infected and providing therapy for latent tuberculosis infection. In 2000, CDC implemented two program evaluation reports for annual submission: Aggregate report of followup for contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection (OMB No. 0920–0457). The respondents for these reports were the 68 state and local tuberculosis control programs receiving federal cooperative agreement funding through DTBE. This group will also respond to this collection of information. These Aggregate reports emphasize treatment outcomes, high-priority target populations vulnerable to tuberculosis, and programmed electronic report entry, which transitioned to the National Tuberculosis Indicators Project (NTIP), a secure web-based system for program evaluation data, in 2010. No other federal agency collects this type of national tuberculosis data, and the Aggregate report of follow-up for contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection are the only data source about latent tuberculosis infection for monitoring national progress toward tuberculosis elimination with these activities. CDC provides ongoing assistance in the preparation and utilization of these reports at the local and state levels of public health jurisdiction. CDC also provides respondents with technical support for NTIP access (Electronic— 100%, Use of Electronic Signatures). The annual burden to respondents is estimated to be 226 hours. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Data clerks and Program Managers (electronic). Program Managers (manual) ............ Data clerks (manual) ......................... Data clerks and Program Managers (electronic). Program Managers (manual) ............ Data clerks (manual) ......................... Number of responses per respondent Tuberculosis 100 1 30/60 Tuberculosis 18 1 30/60 Tuberculosis 18 1 3 Tuberculosis 100 1 30/60 Tuberculosis 18 1 30/60 Tuberculosis Follow-up and Treatment of Contacts to Cases Form. Follow-up and Treatment of Contacts to Cases Form. Follow-up and Treatment of Contacts to Cases Form. Targeted Testing and Treatment for Latent Infection. Targeted Testing and Treatment for Latent Infection. Targeted Testing and Treatment for Latent Infection. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–23072 Filed 9–23–16; 8:45 am] BILLING CODE 4163–18–P 18 1 3 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–R–70, CMS–R– 72, CMS–R–247, CMS–10062, CMS–10268, CMS–10615 and CMS–10623] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services. ACTION: Notice. mstockstill on DSK3G9T082PROD with NOTICES AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to SUMMARY: VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Average burden per response (in hours) Number of respondents Form name publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. E:\FR\FM\26SEN1.SGM 26SEN1

Agencies

[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66030-66031]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23072]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-0457]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written

[[Page 66031]]

comments should be received within 30 days of this notice.

Proposed Project

    Aggregate Reports for Tuberculosis Program Evaluation (OMB Control 
Number 0920-0457)--Reinstatement Without Change of a Previously 
Approved Collection--National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    CDC, NCHHSTP, Division of Tuberculosis Elimination (DTBE) proposes 
a reinstatement without change of the Aggregate Reports for 
Tuberculosis Program Evaluation, previously approved under OMB Control 
Number 0920-0457. This request is for a three-year clearance. There are 
no revisions to the report forms, data definitions, or reporting 
instructions.
    DTBE is the lead agency for tuberculosis elimination in the United 
States. To ensure the elimination of tuberculosis in the United States, 
CDC monitors indicators for key program activities, such as finding 
tuberculosis infections in recent contacts of cases and in other 
persons likely to be infected and providing therapy for latent 
tuberculosis infection.
    In 2000, CDC implemented two program evaluation reports for annual 
submission: Aggregate report of follow-up for contacts of tuberculosis, 
and Aggregate report of screening and preventive therapy for 
tuberculosis infection (OMB No. 0920-0457). The respondents for these 
reports were the 68 state and local tuberculosis control programs 
receiving federal cooperative agreement funding through DTBE. This 
group will also respond to this collection of information.
    These Aggregate reports emphasize treatment outcomes, high-priority 
target populations vulnerable to tuberculosis, and programmed 
electronic report entry, which transitioned to the National 
Tuberculosis Indicators Project (NTIP), a secure web-based system for 
program evaluation data, in 2010. No other federal agency collects this 
type of national tuberculosis data, and the Aggregate report of follow-
up for contacts of tuberculosis, and Aggregate report of screening and 
preventive therapy for tuberculosis infection are the only data source 
about latent tuberculosis infection for monitoring national progress 
toward tuberculosis elimination with these activities.
    CDC provides ongoing assistance in the preparation and utilization 
of these reports at the local and state levels of public health 
jurisdiction. CDC also provides respondents with technical support for 
NTIP access (Electronic--100%, Use of Electronic Signatures).
    The annual burden to respondents is estimated to be 226 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                       Average
                                                                         Number of      Number of     burden per
           Type of respondent                       Form name           respondents   responses per    response
                                                                                       respondent     (in hours)
----------------------------------------------------------------------------------------------------------------
Data clerks and Program Managers          Follow-up and Treatment of            100               1        30/60
 (electronic).                             Contacts to Tuberculosis
                                           Cases Form.
Program Managers (manual)...............  Follow-up and Treatment of             18               1        30/60
                                           Contacts to Tuberculosis
                                           Cases Form.
Data clerks (manual)....................  Follow-up and Treatment of             18               1            3
                                           Contacts to Tuberculosis
                                           Cases Form.
Data clerks and Program Managers          Targeted Testing and                  100               1        30/60
 (electronic).                             Treatment for Latent
                                           Tuberculosis Infection.
Program Managers (manual)...............  Targeted Testing and                   18               1        30/60
                                           Treatment for Latent
                                           Tuberculosis Infection.
Data clerks (manual)....................  Targeted Testing and                   18               1            3
                                           Treatment for Latent
                                           Tuberculosis Infection.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-23072 Filed 9-23-16; 8:45 am]
 BILLING CODE 4163-18-P